GFB-024

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameGFB-024
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsDiabetes ComplicationsEndocrine System DiseasesDiabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharma
China Registration ClassN/A

Develop Information

Active CompaniesGoldfinch Bio Inc
Inactive CompaniesN/A
Active IndicationsDiabetes ComplicationsDiabetes MellitusDiabetic Nephropathies +[4] 
Inactive IndicationsEndocrine System Diseases

Other Information

ATC CodeN/A
Related LinksN/A